STABLE LIPOSOMAL NEBULIZING INHALATION FORMULATIONS FOR CONTROLLED PULMONARY DELIVERY SYSTEMS

• 1. 一种用于呼吸系统疾病的沙丁胺醇脂质体吸入剂 [P] . 中国专利： CN111904954A . 2020-11-10
• 2. 以新生儿CPAP装置临床且经济上可行地输送吸入剂量的气溶胶系统和接口的设计 [P] . 中国专利： CN113874059A . 2021-12-31
• 3. STABLE LIPOSOMAL NEBULIZING INHALATION FORMULATIONS FOR CONTROLLED PULMONARY DELIVERY SYSTEMS [P] . IN2004MU00517A . 2006-09-29

  机译： 受控的肺输送系统的稳定脂质体吸入吸入剂

• 4. AEROSOL FORMULATIONS FOR DELIVERY OF DIHYDROERGOTAMINE TO THE SYSTEMIC CIRCULATION VIA PULMONARY INHALATION [P] . IN2011DN09621A . 2012-12-21

  机译： 通过肺部吸入将二氢异烟酰胺输送至系统循环的气雾剂配方

• 5. Aerosol formulations for delivery of dihydroergotamine to the systemic circulation via pulmonary inhalation [P] . AU2011239367A1 . 2011-11-17

  机译： 通过肺吸入将二氢麦角胺递送至全身循环的气雾剂

• 1. Pulmonary delivery of liposomal dry powder inhaler formulation for effective treatment of idiopathic pulmonary fibrosis [J] . S.Chennakesavulu, A.Mishra, A.Sudheer, 亚洲药物制剂科学(英文) . 2018,第001期
• 2. Novel approaches for posterior segment ocular drug delivery with folate-modified liposomal formulation [J] . Toshiki Hayashi, Risako Onodera, Kohei Tahara, 亚洲药物制剂科学(英文) . 2016,第001期
• 3. Liposomal formulations for enhanced lymphatic drug delivery [J] . Hyeongmin Kim, Yeongseok Kim, Jaehwi Lee 亚洲药物制剂科学(英文) . 2013,第002期
• 4. Spray freeze drying of small nucleic acids as inhaled powder for pulmonary delivery [J] . Wanling Liang, Alan Y.L.Chan, Michael Y.T.Chow, 亚洲药物制剂科学(英文) . 2018,第002期
• 5. Liposomal Cyclosporine A (L-CsA) via Inhalation to Treat Bronchiolitis Obliterans Syndrome: Novel Formulation and Drug-Specific Delivery System Improves Tolerability [J] . Henig N., Teichmann J., Paulukat J., The Journal of heart and lung transplantation: the official publication of the International Society for Heart Transplantation . 2019,第4Suppla期
• 6. Recent Advances in Inhaled Formulations and Pulmonary Insulin Delivery Systems [J] . Liu Haofan, Shan Xiaosong, Yu Jiaojiao, Current Pharmaceutical Biotechnology . 2020,第3期
• 7. Inhaled formulations and pulmonary drug delivery systems for respiratory infections [J] . Zhou Qi (Tony), Leung Sharon Shui Yee, Tang Patricia, Advanced drug delivery reviews . 2015,第Null期
• 8. Characterization of Nebulized Liposomes: Preliminary Studies for Inhalative Application of a Liposomal Drug Delivery System for Vasoactive Intestinal Peptide [C] . Brigitte Stark, Fritz Andreae, Ruth Prassl Controlled Release Society Annual Meeting and Exposition . 2007
• 9. Generation and characterization of fine and stable powders suitable for pulmonary drug delivery using carbon dioxide-assisted nebulization with a Bubble Dryer (CAN-BD). [D] . Villa, Joseph Anthony. 2004
• 10. Pulmonary delivery of liposomal dry powder inhaler formulation for effective treatment of idiopathic pulmonary fibrosis [O] . S. Chennakesavulu, A. Mishra, A. Sudheer, 2018
• 11. Assessment of recent nebulizer delivery systems using urinary pharmacokinetics method and aerodynamic characteristics of TOBI ® nebulized dose following inhalation [O] . M. Mashat, B.J. Clark, K.H. Assi, 2017

• 1. Formulation Development of a Carrageenan Based Delivery System for Buccal Drug Delivery Using Ibuprofen as a Model Drug [J] . Farnoosh Kianfar ,Milan D. Antonijevic ,Babur Z. Chowdhry . 生物材料与纳米技术（英文） . 2011,第5期
• 2. 中药气道吸入剂在肺系感染性疾病中的应用概况 [C] . 明溪 . 第25届全国中医儿科学术研讨会暨中医药高等教育儿科教学研究会会议 . 2008
• 3. 吸入布地奈德福莫特罗粉吸入剂联合口服补肺胶囊治疗COPD稳定期（肺气虚证）病人的临床观察 [A] . 李精浪 . 2017